Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAYER HLTHCARE

  • FDA Approval
  • Nov. 21, 2023, 16:25 UTC
  • 39
  • 0 comments

FDA approve AZELASTINE HYDROCHLORIDE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 39
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 39
  • 0 comments

FDA approve TEMAZEPAM

Comment Full text

LUPIN LTD

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 33
  • 0 comments

FDA approve PITAVASTATIN CALCIUM

Comment Full text

EUGIA PHARMA SPECLTS

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 36
  • 0 comments

FDA approve CYCLOPHOSPHAMIDE

Comment Full text

AMNEAL

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 35
  • 0 comments

FDA approve ESTRADIOL

Comment Full text

SUN PHARM

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 42
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 38
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

DEXCEL

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 39
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Nov. 20, 2023, 09:44 UTC
  • 45
  • 0 comments

FDA approve DABIGATRAN ETEXILATE MESYLATE

Comment Full text
  • Previous
  • 632
  • 633
  • 634
  • 635
  • 636
  • Next

Search

News categories

  • Technical Exchange News(13176)
  • Event(6229)
  • SEC News(331136)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(184866)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin